Jonathan Guarino
Finanzdirektor/CFO bei SOLIGENIX, INC.
Vermögen: 231 $ am 31.05.2024
Aktive Positionen von Jonathan Guarino
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SOLIGENIX, INC. | Finanzdirektor/CFO | 11.09.2019 | - |
| Unternehmenssekretär | - | - | |
| Corporate Officer/Principal | 11.09.2019 | - |
Karriereverlauf von Jonathan Guarino
Ehemalige bekannte Positionen von Jonathan Guarino
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.09.2016 | 01.07.2019 |
| Suite-K Value Added Services LLC | Comptroller/Controller/Auditor | 01.08.2015 | 01.09.2016 |
| COVANCE INC. | Comptroller/Controller/Auditor | 01.06.2014 | 01.05.2015 |
Ausbildung von Jonathan Guarino
| Montclair State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
| Suite-K Value Added Services LLC |
- Börse
- Insiders
- Jonathan Guarino
- Erfahrung